Drugs / CD34+ stem cell therapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06154044 | May 2022 → Dec 2028 expected | heart failure | University Medical Centre Ljubljana | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD34+ stem cell therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06154044 ↗ |
| Modality | Cell therapy | “autologous CD34+ cell therapy” NCT06154044 ↗ |